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Abstract 
Driving under the influence of drugs (DU1D) has been a statutory offence in Ireland since the 
1961 Road Traffic Act. The Medical Bureau of Road Safety (MBRS) is the independent forensic 
body responsible for chemical testing of intoxicants under that Act. There are graded penalties for 
driving under the influence of alcohol, dependant on concentration. The law does not set 
prohibited concentrations for drugs nor does it distinguish between legal and illegal drugs. In 
recent years there has been an increase in the requests by Gardai (police) for analyses for the 
presence of a drug or drugs. As part of the Irish Governments Strategy for Road Safety 1998 - 
2002, the MBRS was commissioned to carry out a nation-wide survey on the current trends and 
epidemiology in DU1D in Ireland. Two thousand blood and urine samples sent to the MBRS 
under the Road Traffic Act 1994 were analysed. 1000 of the specimens were over the limit for 
alcohol and 1000 specimens were under the limit. Specimens were initially analysed for alcoho1 
concentration by HS Gas Chromatography. They were then analysed for the presence of the 
following drugs or drug classes: amphetamines, methamphetamine, benzodiazepines, cannabis, 
cocaine, opiates and methadone using an enzyme immunoassay technique. Specimens found 
positive were sent to the State laboratory for confirmatory analysis by GC-MS or LC-MS for all 
drug types found. Up to October 2001, over 1800 specimens were analysed and the preliminary 
results indicate 46% under the legal alcohol limit and 26% over the legal limit contain drugs. 
Polydrug use was observed at a level of 31 % in the over the legal alcohol limit and 62% under 
the legal limit. The most common class found was cannabis and the least common drug was 
cocaine. These results indicate an increase in DU1D -since a previous survey in 1991. 
Confirmation of the findings will be presented and the distribution of drug types wilt be outlined, 
The high percentage drug positives found in the specimens tested indicates the need for analysis 
for the presence of drugs of all DU1D specimens. The high number of polydrug use detected 
gives rise for concern. The legislation with regard to drugs/driving will be reviewed in light of the 
findings, both analytical and epidemic logical. The importance of these findings from one of the 
larger European studies in relation to road safety is clear. 
 
 
Introduction 
Driving under the influence of drugs (DUID) has been a statutory offence in Ireland since the 
1961 Road Traffic Act. The Medical Bureau of Road Safety (MBRS) is the independent forensic 
body responsible for chemical testing of intoxicants under the Act. There are graded penalties for 
driving under the influence of alcohol, dependent on concentration. The law docs not set 
prohibited concentrations for drugs nor does it distinguish between legal and illegal drugs. In 
recent years there has been an increase in the requests by Gardai (Irish Police) for analysis for the 
presence of drug or drugs to the MBRS. Table 1 outlines the increases over the past seven years. 
The true incidence of drug use combined with driving is not known in Ireland. This is part 
explained by the absence of random breath alcohol testing or roadside drug screening provisions 
in the legislation. 
Table 1 
The number of specimens analysed for alcohol and drugs in Ireland in recent years 
Year Specimen Type Alcohol Analysis Drug Analysis
1995 B&U 4766 8 
1996 B&U 5514 16 
1997 B&U 6591 24 
1998 B&U 7S12 32 
1999 B&U 8476 50 
2000 B&U&BR* 10,134 78 
2001 B&U&BR* 12,503 130 
* Evidential breath testing/or alcohol introduced late 1999. 
Studies have been carried out in other European countries, some on road traffic fatalities or 
accidents (1-4). Other studies have been carried out on impaired drivers (5-6). An attempt to co-
ordinate a direct comparison between countries was carried out for five Nordic countries (7). That 
study examined all blood specimens received by Nordic Forensic Institutes for one week in 1996. 
De Gier in his work for The Pompidou Group of the Council of Europe, on illicit drug and traffic 
safety in Europe, identified that prevalence data from different countries are not comparable due 
to differences in the set-up of the studies (8). This lack of standardised selection outlines the need 
for each country to assess the DUID situation in its own jurisdiction. 
Objectives 
It was decided as part of the Irish Governments Strategy for Road Safety 1998-2002, to 
commission the MBRS to carry out a nationwide survey on the current trends and epidemiology 
in DUID in Ireland in 2000-2001. This study outlines the preliminary analytical findings of the 
survey. 
 
 
 
 
 
Method 
Sample Selection 
Two thousand blood and urine samples sent to the MBRS under the Road Traffic Act 1994 were 
selected. 1000 specimens were over the legal limit for alcohol and 1000 were under the limit. The 
1994 RTA set the alcohol limits of 80mg/100ml in blood 107mg/100ml in urine and 35ug/100ml 
m breath. 
In December 1999, the MBRS installed 4 Evidential Breath Testing (EBT) instruments m Garda 
Stations. In 2000 the MBRS installed 21 EBT instruments throughout the country. The first 500 
over the limit specimens were provided when only the 4 instruments had been installed and the 
second 500 over the limit specimens were provided by end of year 2000 when 25 instruments 
were installed. The 1000 blood or urine under the limit specimens were collected over a longer 
time period from late 1999 to end of 2001. 
The blood or urine samples were taken from Irish drivers apprehended by the Gardai and 
suspected of driving under the influence of an intoxicant. The law defines an intoxicant as 
including alcohol and drugs and any combination of drugs or of drugs and alcohol. 
MBRS Analyses 
All specimens were analysed for alcohol on receipt or shortly afterwards by Headspace Gas 
Chromatography. Specimens were stored at 4°C until analysed for the presence of a drug or drugs 
using an Elisa system. The microplate enzyme immunoassay kits were purchased from COZART, 
UK (sec Table 2 List of Analytes Detected). 
Table 2 
Cozart kits used by the MBRS to analyse for the presence of a drug or drugs in blood and urine 
specimens 
Kit Analyte 
Amphetamine Amphetamine 
Methylenedioxy amphetamine (MDA) 
Methamphetamine Methylenedioxy meth amphetamine (MDMA) 
Benzodiazepine Diazepam, Flunitrazepam, Flurazepam 
Nitrazepam, Nordiazepam, Tcmazcpam 
Cannabinoids 11 nor-delta - 9 carboxy - tetrahydrocannabinol 
Cocaine Cocaine, Benzolyecgonine, Ecgonine methyl ester 
Opiates Codeine, Dihydrocodeine, Morphine 
6 Monoacctylmorphine (MAM) 
Mcthadone Methadone, 2-ethyhdene – l,5-dimethyl – 3,3 – 
diphenylpyrrolidine (EDDP) 
All specimens were analysed for the presence of the following drug or drug classes: 
amphetamines, memamphetamines, benzodiazepines, cannabinoids, cocaine, opiates and 
methadone. 
 
Screening Cut-Off concentrations are outlined in Table 3. 
Specimens found positive were forwarded to the State Laboratory for confirmatory analysis. 
State Laboratory Analyses 
All specimens were frozen on receipt in the State Laboratory and analysed by either GC-MS or 
LC-MS over the period of the survey and to date. The specimens were confirmed positive using 
drug limits of detection (LCD) as outlined in Table 3. 
Table 3 
Screening cut-off concentrations and confirmation LOD levels 
Drug/Drug Classes Screening Cut Off 
(ng/ml) 
Confirmation Cut Off 
(ng/ml) at LOD 
Amphetamines 50 (B) 300 (U) 50 (B) 50 (U) 
Mcthamphetamines 50 (B) 300 (U) 20 (B) 50 (U) 
Bcnzudiazepines *50 (B) 50 (U) 20 (B) 20 (U) 
Cannabinoids *10(B) 10 (U) 5 (B) 5 (U) 
Cocaine 100(B) 100(U) 50 (B) 50 (U) 
Opiates *25 (B) 25 (U) 50 (B) 50 (U) 
Methadone 25 (B) 25 (U) 30 (B) 30 (U) 
* After consultation with State Laboratory, the following cut-off levels were adjusted upward; 
Benzodiazepines and Opiates to 100ng/ml and Cannabinoids to 20ng/ml. 
Results 
The number of specimens forwarded to the St ate Laboratory for confirmatory analysis was 722 
(36% of the 2000) based on Elisa results. 46% of the under the legal alcohol limit specimens and 
26% of over the legal limit specimens indicated the presence of drugs. The number of results 
confirmed to date is 391 (19.6% of the 2000) with 74 specimen results outstanding. The number 
of drug positive specimens with alcohol levels below the limit was 263 (26% of that 1000) with 
113(11%) specimens positive for drugs only. The number of drug positive specimens with alcohol 
levels above the limit was 128 (13% of that 1000). The frequencies of individual drug/drugs 
classes found are shown in Table 4. 
Table 4 
The frequencies of individual drug/drugs classes found 
Drug/Drug Classes Specimens >alcohol limit Specimens <alcohol limit
Amphetamines 14 73 
Methamphetamines 14 72 
Benzodiazepines 33 79 
Cannabinoids 79 156 
Cocaine 9 17 
Opiates 6 57 
Methadone 6 56 
 
 
Table 5 outlines the drugs found in the blood and urine specimens for both over and under the 
alcohol limit. 
Table 5 
Frequency of drugs found in blood and urine specimens 
 Blood > 
alcohol limit
Blood < 
alcohol limit
Urine > 
alcohol limit
Urine < 
alcohol limit
Total 61 112 67 151 
   
Cannabis 27 49 52 107 
Amphetamines 3 24 11 49 
M eth 5 31 9 41 
Opiates 2 10 4 47 
Cocaine 2 3 7 14 
Methadone 1 15 5 41 
Benzodiazepines 27 45 6 34 
The frequency of polydrug use was found to be 139 (36% of 391 confirmed). Again the 
frequencies are given for the different categories in Table 6. 
Table 6 
Drug Survey - Polydrug Frequency 
Drug Classes Positive Over Limits Drug Classes Positive Under Limits
1 Drug 113 1 Drug 139 
2 Drug 8 2 Drug 58
3 Drug 6 3 Drug 49 
4 Drug 1 4 Drug 14 
5 Drug 0 5 Drug 3 
6 Drug 0 6 Drug 0 
7 Drug 0 7 Drug 0 
Discussion 
The results of this large study indicated that 36% of all specimens screened positive for the 
presence of a drug or drugs excluding alcohol, A more reliable figure of 20% were confirmed 
positive by GC-M.S or LC-MS. Initial identification or cut off values for the Elisa analysis were 
chosen based on the low control values issued with the Elisa assay kits. These values were 
increased during the study to give greater concordance in specimen selection between screening 
and confirmatory analysis. The figure of 20% positives is in close agreement with the results 
reported by Denmark, Finland and Iceland using a smaller sample size (7). It has been suggested 
that the higher levels of detection in Norway and Sweden may be attributed to the different 
selection criteria made by the police in the different countries. The most common drug 
encountered apart from alcohol was cannabis. Similar findings have been reported in other 
European countries such as France (3) and Switzerland (5). 
 
 
In the study of the five Nordic countries only Denmark found cannabis to be the most common 
drug (7). Recently in Scotland morphine has surpassed cannabis as the most common illegal drug 
detected in DUID drivers (6). 
The high percentage of drug positives found in the specimens tested indicates the need for 
analysis for the presence of drugs in all DUID specimens. Since the beginning of this year 2002 
the MBPS analyse all the under the limit for alcohol specimens for the presence of drugs. 
The high number of poly drug and alcohol and drug use detected gives rise for concern. The 
legislation with regard to DUID will be review ed in light of the findings both analytical and 
epidemiological. The importance of these findings from one of the larger European studies in 
relation to road safety is clear. 
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